To the content
1 . 2021

Extirpation and prosthetics of the superior vena cava in recurrent thymoma B3

Abstract

Background. It is known that the frequency of local recurrence of thymoma B3 after thymectomy can reach 8-30% of cases. However, even if it is necessary to resect adjacent mediastinal atomic structures, the proportion of repeated radical operations according to the literature is 45-71%, which provides an overall 5-year survival rate of 72%.

The aim of the work is to present a clinical case of successful removal of recurrent thymoma B3 with extirpation and prosthetics of the superior vena cava.

Material and methods. The 59-year old patient, was admitted to the hospital with a clinical diagnosis: malignant neoplasm of the thymus gland, thymoma B3. Surgical treatment 2010. Relapse 2018. Chemoradiotherapy December 2018 (SOD 35 Gr + carboplatin, 3 courses). Stabilization. A planned sternotomy, removal of a recurrent tumor, extirpation and prosthetics of the superior vena cava using a Y-shaped prosthesis with resection of both diaphragmatic nerves were performed. The early postoperative period was complicated by respiratory failure due to bilateral paresis of the diaphragm, which was stopped by prolonged artificial ventilation, rehabilitation and rehabilitation treatment.

Results. At the control examination after 12 months, the patient's condition is satisfactory, he is able to perform moderate physical labor, there is no data for the recurrence of the tumor process in the mediastinum, there is incomplete recanalization of the left brachiocephalic branch of the Y-shaped prosthesis of the superior vena cava. According to spirometry - moderate restrictive violations of pulmonary ventilation.

Conclusion. Surgical treatment of recurrent invasive thymoma with extirpation and prosthetics of the superior vena cava allows us to hope for favorable immediate and long-term results.

Keywords:recurrent thymoma, prosthetics of the superior vena cava

Funding. The study had no sponsor support.
Conflict of interests. The authors declare no conflict of interests.
For citation: Kononets P.V., Charchyan E.R., Abdullaev A.G., Sytov A.V., Obukhova O.A., Eltsov I.V. Extirpation and prosthetics of the superior vena cava in recurrent thymoma B3. Clinical and Experimental Surgery. Petrovsky Journal. 2021; 9 (1): 84-8. DOI: https://doi.org/10.33029/2308-1198-2021-9-1-84-88 (in Russian)

References

1.    Guerrera F., Rendina E., Venuta F., et al. Does the World Health Organization histological classification predict outcomes after thymomectomy? Results of a multicenter study on 750 patients. Eur J Cardiothorac Surg. 2015; 48 (1): 48-54. DOI: https://doi.org/10.1093/ejcts/ezu368

2.    Kaba E, Ozkan B, Ozyurtkan M.O., et al. Superior vena cava resection and reconstruction in mediastinal tumors and benign diseases. Turk Gogus Kalp Damar Cerrahisi Derg. 2018; 26 (1): 99-107. DOI: https://doi.org/10.5606/tgkdc.dergisi.2018.14292

3.    Koper B, Kaplan T, Gdnal N., et al. Long-term survival after R0 resection of thymoma. Asian Cardiovasc Thorac Ann. 2018; 26 (6): 461-6.

4.    Kondo K., Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg. 2003; 76 (3): 878-84.

5.    Lee G.D., Kim H.R., Choi S.H., et al. Prosthetic graft interposition of the brachiocephalic veins or superior vena cava combined with resection of malignant tumours: graft patency and risk factors for graft occlusion. J Thorac Dis. 2016; 8 (1): 61-7. DOI: https://doi.org/10.3978/j.issn.2072-1439. 2016.01.07

6.    Maurizi G., Poggi C., D’Andrilli A., Vanni C., et al. Superior vena cava replacement for thymic malignancies. Ann Thorac Surg. 2019; 107 (2): 386-92. DOI: https:// doi.org/10.1016/j.athoracsur. 2018.08.060.

7.    Raica M., Ribatti D. Head and neck: thymus: thymoma: an overview. Atlas Genet Cytogenet Oncol Haematol. 2013; 17 (3): 221-8.

8.    Rena O., Papalia E., MaggiG., et al. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer. 2005; 50 (1): 59-66.

9.    Weissferdt A., Kalhor N. Bishop J., et al. Thymoma: a clinicopathological correlation of 1470 cases. Hum Pathol. 2018; 73: 7-15. DOI: https://doi.org/10.1016/j.humpath.2017.08.018

10.    Zhao J., Bhatnagar V., Ding L., et al. A systematic review of paraneoplastic syndromes associated with thymoma: treatment modalities, recurrence, and outcomes in resected cases. J Thorac Cardiovasc Surg. 2020; 160 (1): 306-14.

CHIEF EDITOR
CHIEF EDITOR
Sergey L. Dzemeshkevich
MD, Professor (Moscow, Russia)
Medicine today

23 - 25 июня в Москве состоится 17-й Международный междисциплинарный конгресс по аллергологии и иммунологии Одной из ключевых тем станет обсуждение результатов испытания первого в мире ингаляционного препарата против коронавируса - МИР 19, разработанного ФМБА. Мероприятие...

ФЛМ приглашает к информационному сотрудничеству в рамках Третьего клиниколабораторного Форума специалистов лабораторной медицины. 24-25 июня 2021 года в г. Санкт-Петербург состоится Третий клинико-лабораторный Форум специалистов лабораторной медицины. Место проведения: ФГБУ...

Уважаемые коллеги! Рады сообщить, что 24-26 мая 2021 года состоится IX Международный междисциплинарный конгресс по заболеваниям органов головы и шеи в очно-заочном формате! ➤ Адрес мероприятия: Москва, Трубецкая, д.8 ➤ Трансляция мероприятия: Образовательный...


Journals of «GEOTAR-Media»